These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26093911)

  • 1. Screening for α-synuclein immunoreactive neuronal inclusions in the hippocampus allows identification of atypical MSA (FTLD-synuclein).
    Rohan Z; Rahimi J; Weis S; Kapas I; Auff E; Mitrovic N; Liberski PP; Sikorska B; Matej R; Kovacs GG
    Acta Neuropathol; 2015 Aug; 130(2):299-301. PubMed ID: 26093911
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.
    Aoki N; Boyer PJ; Lund C; Lin WL; Koga S; Ross OA; Weiner M; Lipton A; Powers JM; White CL; Dickson DW
    Acta Neuropathol; 2015 Jul; 130(1):93-105. PubMed ID: 25962793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-standing multiple system atrophy-Parkinsonism with limbic and FTLD-type α-synuclein pathology.
    Coughlin DG; Dryden I; Goodwill VS; Pizzo DP; Wright B; Lessig S; Galasko D; MacKenzie IR; Hiniker A
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12783. PubMed ID: 34847258
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
    Armstrong RA; Cairns NJ; Lantos PL
    Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy.
    Baker KG; Huang Y; McCann H; Gai WP; Jensen PH; Halliday GM
    Acta Neuropathol; 2006 Feb; 111(2):193-5. PubMed ID: 16421739
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal change multiple system atrophy: an aggressive variant?
    Ling H; Asi YT; Petrovic IN; Ahmed Z; Prashanth LK; Hazrati LN; Nishizawa M; Ozawa T; Lang A; Lees AJ; Revesz T; Holton JL
    Mov Disord; 2015 Jun; 30(7):960-7. PubMed ID: 25854893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration.
    Nakamura K; Mori F; Kon T; Tanji K; Miki Y; Tomiyama M; Kurotaki H; Toyoshima Y; Kakita A; Takahashi H; Yamada M; Wakabayashi K
    Neuropathology; 2016 Apr; 36(2):157-67. PubMed ID: 26331967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy variant with severe hippocampal pathology.
    Ando T; Riku Y; Akagi A; Miyahara H; Hirano M; Ikeda T; Yabata H; Koizumi R; Oba C; Morozumi S; Yasui K; Goto A; Katayama T; Sakakibara S; Aiba I; Sakai M; Konagaya M; Mori K; Ito Y; Yuasa H; Nomura M; Porto KJL; Mitsui J; Tsuji S; Mimuro M; Hashizume Y; Katsuno M; Iwasaki Y; Yoshida M
    Brain Pathol; 2022 Jan; 32(1):e13002. PubMed ID: 34255887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration-TDP with 'multiple system atrophy phenocopy syndrome'.
    Sousa AL; Taipa R; Quinn N; Revesz T; Pires MM; Magalhães M
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):533-536. PubMed ID: 28181693
    [No Abstract]   [Full Text] [Related]  

  • 14. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
    Kovacs GG; Wagner U; Dumont B; Pikkarainen M; Osman AA; Streichenberger N; Leisser I; Verchère J; Baron T; Alafuzoff I; Budka H; Perret-Liaudet A; Lachmann I
    Acta Neuropathol; 2012 Jul; 124(1):37-50. PubMed ID: 22370907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.
    Miller DW; Johnson JM; Solano SM; Hollingsworth ZR; Standaert DG; Young AB
    J Neural Transm (Vienna); 2005 Dec; 112(12):1613-24. PubMed ID: 16284907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models of multiple system atrophy.
    Stefanova N; Reindl M; Poewe W; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S53-6. PubMed ID: 16092091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary neuronal loss is not associated with α-synuclein burden in multiple system atrophy.
    Coon EA; Schmeichel AM; Parisi JE; Cykowski MD; Low PA; Benarroch EE
    Mov Disord; 2016 Dec; 31(12):1802-1809. PubMed ID: 27629118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.